THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

Trine Alma Knudsen (Foredragsholder), Lund Hansen, D. (Andet), Lucas Frans Ocias (Andet), Weiss Bjerrum, O. (Andet), Brabrand, M. (Andet), Christina Ellervik (Andet), Daniel el Fassi (Andet), Frederiksen, M. (Andet), Lasse Kjær (Andet), Thomas Kielsgaard Kristensen (Andet), Kruse, T. A. (Underviser), Hans Torben Mourits-Andersen (Andet), Peter Møller (Andet), Ulrik Malthe Overgaard (Andet), Dustin Andersen Patel (Andet), Marianne Tang Severinsen (Andet), Vibe Skov (Andet), Anders Lindholm Sørensen (Andet), Stentoft Jesper (Andet), Jørn Starklint (Andet), Karin de Stricker (Andet), Thomassen, M. (Andet), Larsen, T. S. (Underviser), C Hasselbalc Hans (Andet)

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode16. jun. 2019
Begivenhedstitel24th European Hematology Association Congress (EHA)
BegivenhedstypeKonference
PlaceringAmsterdam, Holland
Grad af anerkendelseInternational